key: cord-0686040-n0bd3rig authors: Martin, Christian title: Human Lung Slices: New Uses for an Old Model date: 2021-03-30 journal: American journal of respiratory cell and molecular biology DOI: 10.1165/rcmb.2021-0268ed sha: 43501d792a81b8db1064298ca1305ff8722429ab doc_id: 686040 cord_uid: n0bd3rig nan active viruses. Most importantly, they found an overlap of strongly induced or suppressed genes of the RV-infected PCLS compared with genomics of brushed primary epithelial cells from patients with asthma and COPD available in a public database (12, 13) . Interestingly, these RV-induced gene expressions for asthma and COPD differed substantially, with only a small overlap between the two groups. Finally, the antiviral treatment of human PCLS by Rupintrivir affected solely the gene regulation of inflammation and not the integrity and healing of the epithelium. This allows for the discrimination of drug action at different stages of the infection process and correlates it to distinct gene regulation patterns. Thus, it permits better insight into mechanisms of drug actions and their consequences. There are some limitations and possible improvements for further research to be discussed. First, the number of patients used for the genomic analysis is relatively small (3-4 patients). Wronski and colleagues referred to the small interpatient differences, but an additional direct comparison of each condition per patient would be helpful in statistical analysis. More details on medical history, such as diseases and premedication, would further strengthen the conclusions. These factors should have an impact on the results of genomic analysis. The use of human PCLS obtained from patients with COPD or asthma followed by a viral infection could elucidate factors and pathways of exacerbation. The production of human lung slices can lead to the availability of a large number of PCLS as well as functional cryopreserved PCLS (2) . Even though the number of viable cells is slightly reduced, thawed PCLS may still be useful for infection experiments. Second, during the slicing process of PCLS, growth factors responsible for wound healing in the tissue are released and induced. In order to distinguish gene inductions caused by the slicing process from the former, the genetic data should be compared to native human lung tissue, which is also available in public databases. Third, human PCLS with small airways, as used by Wronski and colleagues, show changes in gene expression and mediator release. This should be compared to possible physiological changes in the same tissue, predominantly airway contraction (14) , ciliary beating, and mucus release. This combination would give deeper insight and possibly yield molecular, immunological, and functional findings. To ameliorate the immunological response in PCLS, methodological improvements would be necessary. The infection process involves local and systemic immune responses, which implies chemotaxis of immune cells. PCLS allow the study mainly of local immune responses, which lack interaction with the circulating immune cells. Cultivation of PCLS in an air-liquid interface and addition of distinct immune cells could yield crucial insight into chemotaxis. Infections by viruses, such as respiratory syncytial virus, enterovirus, influenza virus, adenovirus, and coronaviruses (15) are responsible for triggering exacerbations of asthma and COPD (2, 3) . Even though RVs are the most prominent, this model of human PCLS should be extended to other viruses. Most importantly, viruses for which infection in other mammals is difficult (like severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] in mice [16] ) should be considered. However, infection with parainfluenza virus in PCLS infects cells beneath the epithelium, which can be accessed by the virus after the slicing process. This is clearly a methodological artifact in PCLS and shows a limitation of the method (15) . In addition, multiple infections often occur simultaneously in patients, and different viruses affect different epithelial cell types. Therefore, the combination of viruses and/or bacteria would be important. In conclusion, the manuscript's in-depth analysis of viral responses is of great methodological importance and a basis for future research. This is crucial for the study of infectious diseases and the treatment of lung diseases. Author disclosures are available with the text of this article at www.atsjournals.org. Christian Martin, Ph.D. Institute of Pharmacology and Toxicology RWTH Aachen University Aachen, Germany COPD readmissions: addressing COPD in the era of value-based health care Rhinovirus and asthma: challenges and opportunities Respiratory viral infection: a potential "missing link" in the pathogenesis of COPD Building and regenerating the lung cell by cell The human lung cell atlas: a high-resolution reference map of the human lung in health and disease Use of precision cut lung slices as a translational model for the study of lung biology The early allergic response in small airways of human precision-cut lung slices Neurally mediated airway constriction in human and other species: a comparative study using precision-cut lung slices (PCLS) Assessment of the cytotoxic and immunomodulatory effects of substances in human precision-cut lung slices U-BIOPRED Study Group. Rhinovirus-induced human lung tissue responses mimic chronic obstructive pulmonary disease and asthma gene signatures Defining critical roles for NF-kB p65 and type I interferon in innate immunity to rhinovirus U-BIOPRED Project Team. A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment Rupintrivir reduces RV-induced T H -2 cytokine IL-4 in precision-cut lung slices (PCLS) of HDM-sensitized mice ex vivo Differential sensitivity of differentiated epithelial cells to respiratory viruses reveals different viral strategies of host infection A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures